First Opinion John F. Crowley STAT Plus: For national security, the U.S. must maintain its biotech dominance
Biotech Robert Weisman — Boston Globe STAT Plus: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership
Biotech Jason Mast STAT Plus: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution
Exclusive Jason Mast STAT Plus: David Liu startup to focus on getting CRISPR therapy to hard-to-reach cells
Biotech Jason Mast STAT Plus: Gene therapy is in crisis. For nine hours, the field’s leading minds looked for a solution